{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:53:36Z","timestamp":1773903216721,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.anaerobe.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:21:21Z","timestamp":1537834881000},"page":"146-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain"],"prefix":"10.1016","volume":"54","author":[{"given":"J.","family":"Arca-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gal\u00e1n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cano-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Garc\u00eda-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Rodr\u00edguez-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2018.09.006_bib1","first-page":"57","article-title":"Review of current literature on the economic burden of Clostridium difficile infection, infect. Control hosp","volume":"30","author":"Dubberke","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BI\/NAP1\/027 strain","volume":"136","author":"O'Connor","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anaerobe.2017.08.007","article-title":"Spatio-temporal variability of the epidemic 027 Clostridium difficile strains in France based on MLVA typing","volume":"48","author":"Couturier","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10096-017-2991-y","article-title":"An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy","volume":"36","author":"Bouza","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijmm.2013.02.016","article-title":"Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain","volume":"303","author":"Weber","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-013-1845-5","article-title":"Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland","volume":"32","author":"Obuch-Woszczaty\u0144ski","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib8","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1128\/JCM.00648-15","article-title":"Genomic epidemiology of a protracted hospital outbreak caused by a toxin a-negative Clostridium difficile sublineage PCR ribotype 017 strain in london, England","volume":"53","author":"Cairns","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/JCM.02482-09","article-title":"Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018","volume":"48","author":"Spigaglia","year":"2010","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/jac\/dkr292","article-title":"Multidrug resistance in European Clostridium difficile clinical isolates","volume":"66","author":"Spigaglia","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JCM.03352-12","article-title":"Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in barcelona, Spain","volume":"51","author":"Rodr\u00edguez-Pardo","year":"2013","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eimc.2017.01.007","article-title":"M.\u00c1. Chiveli Monle\u00f3n, P. Anguita-Alonso, E. Bouza-Santiago, J. Garnacho-Montero, Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: the PROCRID study","volume":"36","author":"Guti\u00e9rrez-Pizarraya","year":"2018","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JCM.37.2.461-463.1999","article-title":"PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes","volume":"37","author":"Stubbs","year":"1999","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.anaerobe.2017.08.012","article-title":"Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection","volume":"48","author":"G\u00f3mez","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/AAC.01252-08","article-title":"Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in\u00a0vitro","volume":"53","author":"Spigaglia","year":"2009","journal-title":"ntimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12064","article-title":"Consequences of Clostridium difficil infection: understanding the healthcare burden","volume":"18","author":"Bouza","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591201","article-title":"High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital","volume":"47","author":"S\u00e1nchez-Somolinos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.10.008","article-title":"The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011 & 2013; 2014","author":"Freeman","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib19","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00524-08","article-title":"Metronidazole resistance in Clostridium difficile is heterogeneous","volume":"46","author":"Pel\u00e1ez","year":"2008","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jac\/dkn313","article-title":"Emergence of reduced susceptibility to metronidazole in Clostridium difficile","volume":"62","author":"Baines","year":"2008","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib21","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/AAC.00220-12","article-title":"Antimicrobial-resistant strains of Clostridium difficile from North America","volume":"56","author":"Tenover","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib22","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.41.19000-en","article-title":"The HPA Regional Microbiology Network, Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08","volume":"13","author":"Brazier","year":"2008","journal-title":"Euro Surveill."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.04082-14","article-title":"Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr","volume":"59","author":"Mar\u00edn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2014.09.004","article-title":"Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012","volume":"31","author":"Lachowicz","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3201\/eid2404.170095","article-title":"Imipenem resistance in Clostridium difficile ribotype 017, Portugal","volume":"24","author":"Isidro","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.eimc.2013.07.004","article-title":"First case of autochthonous Clostridium difficile PCR ribotype 027 detected in Spain","volume":"32","author":"Mar\u00edn","year":"2014","journal-title":"Enfermedades Infecc. Microbiol. Cl\u00ednica"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.anaerobe.2018.09.006_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetmic.2016.12.001","article-title":"Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078\/126 isolates of human and animal origin","volume":"199","author":"\u00c1lvarez-P\u00e9rez","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1099\/jmm.0.47738-0","article-title":"Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe","volume":"57","author":"Spigaglia","year":"2008","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2007.03.009","article-title":"Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile","volume":"59","author":"Schmidt","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2018.09.006_bib32","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/jac\/dkr275","article-title":"PCR ribotype prevalence and molecular basis of macrolide\u2013lincosamide\u2013streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates","volume":"66","author":"Solomon","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996418301616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996418301616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T18:32:11Z","timestamp":1605033131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996418301616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"alternative-id":["S1075996418301616"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2018.09.006","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}